project id: TCGA-BLCA; case submitter id: TCGA-DK-A3WY; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.2; age at index: 67; days to birth: -24536; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1934; age at diagnosis: 24536; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 4967.0; icd 10 code: C67.1; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Dome of bladder; synchronous malignancy: No; tissue or organ of origin: Dome of bladder; tumor grade: Not Reported; year of diagnosis: 2001; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 4107; days to sample procurement: 0; initial weight: 430.0; portion submitter id: TCGA-DK-A3WY-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 80.0;